Eubiotics Market Report 2025

The eubiotics market size has grown strongly in recent years. It will grow from $5.85 billion in 2024 to $6.38 billion in 2025 at a compound annual growth rate (CAGR) of 9%. The growth in the historic period can be attributed to rising consumer awareness of healthy diets, focus on livestock health and performance, antibiotic resistance concerns, increasing meat consumption, research and development investments.

The eubiotics market size is expected to see strong growth in the next few years. It will grow to $8.95 billion in 2029 at a compound annual growth rate (CAGR) of 8.8%. The growth in the forecast period can be attributed to emergence of eubiotic blends, growing trend of sustainable agriculture, expansion of dairy industry, application in horse nutrition, integration of prebiotics and postbiotics, rising demand for antibiotic-free products. Major trends in the forecast period include replacement of antibiotic growth promoters (AGPs), prebiotics and probiotics dominance, regulatory emphasis on antibiotic reduction, advancements in microbial solutions, sustainable and eco-friendly practices, and expansion in aquaculture applications, collaborations and partnerships.

The growing livestock population in the eubiotics market is expected to boost market growth during the forecast period. Livestock encompasses various breeds of animals raised for commercial purposes, including both domestic and wild species. The increase in livestock numbers is largely due to their use for commercial activities, such as the sale of milk, eggs, chicken, and fiber products. For example, in May 2024, a report from the Brazilian Institute of Geography and Statistics indicated that Brazil reported the slaughter of 57.17 million hogs and pigs, with a slight decline in Q1 2024 to 13.92 million, representing a 1.8% decrease compared to the same quarter in 2023. Nevertheless, Brazil remains a significant player in the global market, exporting large quantities of pork, chicken, and beef, particularly to countries like China and those in the Middle East. Thus, the increasing use of livestock for commercial purposes is expected to drive the growth of the eubiotics market in the coming years.

The rising demand for high-quality animal feeds is anticipated to accelerate the growth of the eubiotics market moving forward. High-quality animal feeds are nutritionally balanced, contaminant-free formulations tailored to meet the specific dietary needs of animals, promoting optimal health, growth, and reproduction. Eubiotics play a crucial role in modern animal nutrition, increasingly used to enhance animal health, minimize antibiotic use, and improve the sustainability of livestock production systems. For instance, in 2023, the American Feed Industry Association, a U.S.-based non-profit organization representing the feed industry, reported that there are nearly 5,650 animal food manufacturing facilities operating across the nation, producing over 284 million tons of finished feed and pet food annually. Therefore, the rising demand for high-quality animal feeds is driving the growth of the eubiotics market.

Product innovation is a significant trend in the eubiotics market, with major players concentrating on developing innovative products to enhance the quality of feed additives within eubiotic offerings. High-quality nutrients, like probiotics, serve as feed additives that improve animal performance by promoting gut health. For example, in October 2022, APC Europe S.L.U., a Spain-based company specializing in high-quality feed additives, introduced APPETEIN GS, a granulated plasma ingredient. This product is designed to improve flowability and reduce dust in feed formulations while consisting of pure porcine proteins, with the goal of enhancing animal welfare and intestinal health.

Key companies in the market are focused on creating innovative products, such as prebiotic fiber, to gain a competitive edge and expand their customer base. Prebiotic fiber is a specialized type of fiber that encourages the growth of beneficial gut bacteria. For instance, in September 2023, Alltech, a U.S.-based nutrition company, launched Microbuild, an advanced prebiotic fiber designed to promote gut health and support a strong microbiome in pets. This innovative prebiotic aims to enhance overall well-being and ensure gut health, even when faced with bacterial challenges. It does so by increasing microbial diversity in the gut, thereby strengthening the animal's natural defenses. As a nutritional technology, Microbuild assists pets in developing a diverse and healthy microbiome, providing noticeable benefits for pet owners who witness improvements in their pets' health. The strength of Microbuild lies in prebiotics, specialized fibers that stimulate the growth of beneficial gut bacteria. Improved fiber digestibility not only aids in nutrient absorption and maintains intestinal integrity but also helps in developing a strong immune system. Microbuild is based on the advanced field of nutrigenomics, which investigates the complex relationship between genetics and nutrition.

In March 2024, Novus International, Inc., a U.S.-based global provider of innovative nutritional solutions, acquired BioResource International, Inc. for an undisclosed sum. Novus International aims to enhance its enzyme product portfolio, strengthen its innovation pipeline, improve supply chain management, support gut health initiatives, and better serve its customers in the animal nutrition sector. BioResource International, Inc. is a U.S.-based biotechnology company that develops enzyme products designed to improve animal nutrition, closely aligning with eubiotic principles to promote gut health in livestock.

Major companies operating in the eubiotics market are BASF SE, Koninklijke DSM NV, Lallemand Inc., Novus International Inc., Chr Hansen Holding A/S, Cargill Inc., Lesaffre Group, Kemin Industries Inc., Evonik Industries AG, Archer Daniels Midland Company, Beneo GmbH, BioResource International Inc., Biomin Holding GmbH, Bluestar Adisseo Company, Dupont Nutrition & Biosciences, Nutreco NV, Pancosma SA, Synbio Tech Inc., Vetagro SpA, Zinpro Corporation, Alltech Inc., Impextraco NV, Nuscience Group, Olmix Group.

Europe was the largest region in the eubiotics market in 2024. The regions covered in the eubiotics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the eubiotics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Eubiotics represent natural digestive feed supplements designed to enhance animal health and bolster immune system functionality. They incorporate a blend of food additives, including prebiotics, probiotics, and polysaccharides, aimed at supporting gut health, immune development, and maintaining optimal microflora in the gastrointestinal tract.

The primary categories of eubiotics encompass probiotics, prebiotics, organic acids, essential oils, and enzymes. Probiotics consist of live microorganisms that contribute to overall health, bolstering immunity and promoting digestive well-being. These microorganisms aid in improving immunity, digestion, gut health, and reducing microbial contamination. Eubiotics are available in various treatment forms such as dry and liquid formulations tailored for applications in livestock including cattle, poultry, swine, aquaculture, and other animals, catering to needs related to gut and digestive health, overall wellness, and immunity support in animals.

The eubiotics market research report is one of a series of new reports that provides eubiotics market statistics, including the eubiotics industry's global market size, regional shares, competitors with a eubiotics market share, detailed eubiotics market segments, market trends and opportunities, and any further data you may need to thrive in the eubiotics industry. This eubiotics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The eubiotics market consists of sales of lactobacilli, bifidobacterium, streptococcus, fructo-oligosaccharides (FOS), inulin, galacto-oligosaccharides (GOS), and mannan-oligosaccharides (MOS). Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.